Homepage Banner

Request a Representative

If you wish to have a representative visit please click here.

Request a Representative

Contact Lilly

If you wish to report an adverse event (side effect) or product complaint with a Lilly product, please call Lilly UK on 01256 315 000 (UK) or 016640446 (Ireland). Additionally reporting forms for adverse events and further information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (Ireland).

Report adverse event

Olumiant Resources

A collection of online resources to further help you understand how Olumiant works and provide you with all the information required to initiate treatment with Olumaint. This includes mechanism of action animations, clinical papers, HCP guides and patient guides, all of which can be downloaded1.

HCP Resources

Prescribing Guide

This is a guide designed to provide you with all the information you should need as a prescriber when initiating treatment with Olumiant.

Patient Brochure

A simple guide to Olumiant for any patient who has been prescribed it to help them get to know their medicine.

Clinical Papers

A number of clinical papers will be available to view and download shortly...

Mechanism of action videos

Take a look below to view and download videos which explain the role JAK inhibitors play in modulating inflammation in rheumatoid arthritis.

Cytokines and their implication in rheumatoid arthritis

The JAK/STAT pathway and rheumatoid arthritis

Mechanism of Action of JAK inhibitors

Olumiant (baricitinib) Mechanism of Action

Olumiant (baricitinib) vs other JAK inhibitors

References

©2018 Eli Lilly and Company. All rights reserved. The Olumiant mark and Olumiant design are the trademarks of Eli Lilly and Company.


Was this page helpful ?